胥振国,蔡玉华,刘修树,范高福,戴银
XU Zhen-guo,CAI Yu-hua,LIU Xiu-shu,FAN Gao-fu,DAI Yin

• 1:合肥职业技术学院
• 2:安徽省农业科学研究院

摘要(Abstract)：

双歧杆菌是一种存在于人体内的益生菌,已成为人体健康的重要指标之一。作为微生态制剂,其对机体有营养、拮抗、通便、增强免疫力,抗肿瘤,抗衰老等多种益生功能,已成为微生态专业领域研究的热点。本文对双歧杆菌的生物学特性、生理功能及分子生物学检测方面国外研究进展作一综述,并对双歧杆菌未来的研究前景进行展望。
Bifidobacterium is a probiotics living in human body, and has become one of important indexes for human health. As a probiotics, bifidobacterium has several beneficial functions including nourishing, antagonism, purging,increasing immunity, anti-tumor and anti-aging, which has become a hotspot in microecological field. This paper summarizes the progress in research on biological properties, physical functions and molecular biological assay as well as the prospect of bifidobacterium.

关键词(KeyWords)： 双歧杆菌;益生菌
Bifidobacterium;Probiotics

Abstract:

Keywords:

基金项目(Foundation): 安徽省教育厅高校领军人物人才引进与培育计划项目:高校优秀青年人才支持计划重点项目(gxyq ZD2016547);; 安徽省高校自然基金研究重点项目(KJ2016A613);; 安徽省高校自然基金研究重点项目(KJ2015A406);; 国家自然科学基金项目(31302044)

作者(Author): 胥振国,蔡玉华,刘修树,范高福,戴银
XU Zhen-guo,CAI Yu-hua,LIU Xiu-shu,FAN Gao-fu,DAI Yin

DOI: 10.13200/j.cnki.cjb.001670

参考文献(References)：

• [1]GOMES A M P,MALCATA F X.Bifidobacterium spp.and Lactobacillus acidophilus:biological,biochemical,technological and therapeutical properties relevant for use as probiotics[J].Trends Food Sci Technol,1999,10(4-5):139-157.
• [2]ISHIBASHI N,YAESHIMA T,HAYASAWA H.Bifidobacteria:their significance in human intestinal health[J].Mal JNutr,1997,3:149-159.
• [3]DI GIOIA D,ALOISIO I,MAZZOLA G,et al.Bifidobacteria:their impact on gut microbiota composition and their applications as probiotics in infants[J].Appl Microbiol Biotechnol,2014,98(2):563-577.
• [4]TURRONI F,VENTURA M,BUTTóL F,et al.Molecular dia-logue between the human gut microbiota and the host:a Lacto-bacillus and Bifidobacterium perspective[J].Cell Mol Life Sci,2014,71(2):183-203.
• [5]NIEVES C,ROWE C,CULPEPPER T,et al.Bifidobacterium bifidum R0071 decreases stress-associated diarrhea-related symptoms and ultimately self-reported stress in a randomized,double-blind,placebo-controlled study[J].FASEB J,2014,28(1 Suppl):647.21.
• [6]PRASAD J,SAZAWAL S,DHINGRA U,et al.Detection of viable Bifidobacterium lactis HN019(DR10TM)in stools of children during a synbiotic dietary intervention trial[J].Int Dairy J,2013,30(2):64-67.
• [7]GOODFELLOW M,KAMPFER P,BUSSE H J,et al.Bergey′s manual of systematic bacteriology[M].New York:Springer Science Business Media,2012,33:2028.
• [8]OBERG T S,WARD R E,STEELE J L,et al.Genetic and physiological responses of Bifidobacterium animalis subsp.lactis to hydrogen peroxide stress[J].J Bacteriol,2013,195(16):3743-3751.
• [9]RANI V U,PRADEEP B V.Application of anticancer agents from fermentation of soy using Bifidobacterium and Lactobacillus spp.,a review[J].Acad J Cancer Res,2014,7(3):185-192.
• [10]BUNESOVV,VLKOVE,KILLER J,et al.Identification of Bifidobacterium strains from faeces of lambs[J].Small Ruminant Res,2012,105(1-3):355-360.
• [11]GONZLEZ-RODRGUEZ I,GASPAR P,SNCHEZ B,et al.Catabolism of glucose and lactose in Bifidobacterium animalis subsp.lactis,studied by 13C nuclear magnetic resonance[J].Appl Environ Microbiol,2013,79(24):7628-7638.
• [12]GAVINI F,DELCESERIE V,KOPEINIG K,et al.Bifidobacterium species isolated from animal feces and from beef and pork meat[J].J Food Prot,2006,69(4):871-877.
• [13]LEBLANC J G,MILANI C,DE GIORI G S,et al.Bacteria as vitamin suppliers to their host:a gut microbiota perspective[J].Curr Opin Biotechnol,2013,24(2):160-168.
• [14]COLLADO M C,GUEIMONDE M,SANZ Y,et al.Adhesion properties and competitive pathogen exclusion ability of bifidobacteria with acquired acid resistance[J].J Food Prot,2006,69(7):1675-1679.
• [15]RUAS-MADIEDO P,GUEIMONDE M,MARGOLLES A,et al.Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus[J].J Food Prot,2006,69(8):2011-2015.
• [16]YILDIRIM Z,JOHNSON M G.Characterization and antimicrobial spectrum of bifidocin B,a bacteriocin produced by Bifidobacterium bifidum NCFB 1454[J].J Food Prot,1998,61(1):47-51.
• [17]SAGAR S,MORGAN M E,CHEN S,et al.Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma[J].Respir Res,2014,15:46.
• [18]KIM O S,CHO Y J,LEE K,et al.Introducing Ez Taxon-e:a prokaryotic 16S r RNA gene sequence database with phylotypes that represent uncultured species[J].Int J Syst Evol Microbiol,2012,62(Pt 3):716-721.
• [19]FANNING S,HALL L J,CRONIN M,et al.Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection[J].Proc Natl Acad Sci USA,2012,109(6):2108-2113.
• [20]DYLAG K,HUBALEWSKA-MAZGAJ M,SURMIAK M,et al.Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders[J].Curr Pharm Des,2014,20(7):1149-1155.
• [21]YUSOF R M,HAQUE F,ISMAIL M,et al.Isolated of Bifidobacteria infantis and its antagonistic activity againt ETECO157 and Salmonella typhimurium S-285 in weaning foods[J].Asia Pac J Clin Nutr,2013,9(2):130-135.
• [22]YANG Y X,HE M,HU G,et al.Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women[J].Word J Gastroenterol,2008,14(40):6237-6243.
• [23]GORE C,CUSTOVIC A,TANNOCK G,et al.Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema:randomized controlled trial with follow up until age 3 years[J].Clin Exp Allergy,2012,42(1):112-122.
• [24]FELESZKO W,JAWORSKA J,RHA R D,et al.Probioticinduced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma[J].Clin Exp Allergy,2007,37(4):498-505.
• [25]MACSHARRY J,O′MAHONY C,SHALABY K H,et al.Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse[J].Pulm Pharmacol Ther,2012,25(4):325-334.
• [26]KWON H K,LEE C G,SO J S,et al.Generation of regulatory dendritic cells and CD4+Foxp3+T cells by probiotics administration suppresses immune disorders[J].Proc Natl Acad Sci USA,2010,107(5):2159-2164.
• [27]ZHANG L L,CHEN X,ZHENG P Y,et al.Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy[J].J Gastroenterol Hepatol,2010,25(5):928-934.
• [28]BURTON O T,DARLING A R,ZHOU J S,et al.Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy[J].Mucosal Immunol,2013,6(4):740-750.
• [29]TURRONI F,TAVERNITI V,RUAS-MADIEDO P,et al.Bifidobacterium bifidum PRL2010 modulates the host innate immune response[J].Appl Environ Microbiol,2013,80(2):730-740.
• [30]WANG L Q,ZHAO F,LIU F,et al.Live/dead state is not the factor influencing adhesion ability of Bifidobacterium animalis KLDS2.0603[J].J Microbiol,2013,51(5):584-589.
• [31]SINGH J,RIVENSON A,TOMITA M,et al.Bifidobacterium longum,a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon arcinogeneses[J].Carcinogenesis,1997,18(4):833-841.
• [32]BASHOLLI-SALIHU M,MUELLER M,SALAR-BEHZADI S,et al.Effect of lyoprotectants on beta-glucosidase activity and viability of Bifidobacterium infantis after freeze-drying and storage in milk and low p H juices[J].LWT-Food Sci Technol,2014,57(1):276-282.
• [33]VERENA J K,BRIGITTE M,REINHARD S,et al.Impact of lactic acid bacteria on oxidative DNA damage in human derived colon cells[J].Food Chem Toxicol,2008,46(4):1221-1229.
• [34]YAMAZAKI S,KANEKO T,TAKETOMO N,et al.2-Amino-3-carboxy1,4-naphthoquinone affects the end-product profile of bifidobacteria through the mediated oxidation of NAD(P)H[J].Appl Microbiol Biotechnol,2002,59(1):72-78.
• [35]EJTAHED H S,MOHTADI-NIA J,HOMAYOUNI-RAD A,et al.Probiotic yogurt improves antioxidant status in type 2 diabetic patients[J].Nutrition,2011,28(5):539-543.
• [36]DELCENSERIE V,BECHOUX N,LONARD T,et al.Discrimination between Bifidobaterium species from human and animal origin by PCR-restriction fragment length polymorphism[J].J Food Prot,2004,67(6):1284-1288.
• [37]LI W,RAOULT D,FOURNIER P E.Bacterial strain typing in the genomic era[J].FEMS Microbiol Rev,2009,33(5):892-916.
• [38]TOSHIMITSU T,NAKAMURA M,IKEGAMI S,et al.Strainspecific identification of Bifidobacterium bifidum OLB6378 by PCR[J].Biosci Biotechnol Biochem,2013,77(3):572-576.
• [39]GULITZ A,STADIE J,EHRMANN M A,et al.Comparative phylobiomic analysis of the bacterial community of water kefir by 16S r RNA gene amplicon sequencing and ARDRA analysis[J].J Appl Microbiol,2013,114(4):1082-1091.
• [40]HOFFMANN M,BROWN E W,FENG P C,et al.PCR-based method for targeting 16S-23S r RNA intergenic spacer regions among Vibrio species[J].BMC Microbiol,2010,10:90.
• [41]TURRONI F,FORONI E,PIZZETTI P,et al.Exploring the diversity of the Bifidobacterial population in the human intestinal tract[J].Appl Environ Microbiol,2009,75(6):1534-1545.
• [42]LI Q,CHEN Q,RUAN H,et al.Isolation and characterisation of an oxygen acid and bile resistant bifidobacterium animalis subsp.lactis Qq08[J].J Sci Food Agric,2010,90(8):1340-1346.
• [43]DELTIOILE A,PASSET V,AIRES J,et al.Species delineation and clonal diversity in four Bifidobacterium species as revealed by multilocus sequencing[J].Res Microbiol,2010,161(2):82-90.
• [44]HIROSHI M,AKIRA K,EIJI I,et al.Transmission of intestinal Bifidobacterium longum subsp.longum strains from mother to infant,determined by multilocus sequencing typing and amplified fragment length polymorphism[J].Appl Environ Microbiol,2011,77(19):6788-6793.